"If the drug of choice is broad spectrum and has rapid action it will be a winner."
Quite possibly - medically speaking.
But how is it going to be a financial winner? How does the company (and its shareholders) make money out of something that an affected patient needs just one treatment of?
RCE Price at posting:
49.0¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)